8-KLeadership ChangesExhibits & Filings

HCA Healthcare, Inc. 8-K Report, Executive Changes (Apr 1, 2016)

Filed April 1, 2016For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on April 1, 2016, to announce the adoption of its 2016 Senior Officer Performance Excellence Program (Senior Officer PEP) by its Compensation Committee. This program outlines the performance-based incentive compensation for the Company's executive officers for fiscal year 2016. The program is designed to align executive rewards with key company objectives, specifically focusing on financial performance and the quality of care delivered. The Senior Officer PEP will award cash bonuses to named executive officers, including the CEO, COO, CFO, and Group Presidents. These awards are primarily weighted towards the achievement of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) targets, accounting for 80% to 90% of the potential award. The remaining 10% to 20% is tied to the achievement of specific quality of care metrics, such as Hospital Acquired Conditions, Core Measures, and Patient Experience. This dual focus aims to incentivize both financial growth and a commitment to high-quality patient outcomes, crucial elements for long-term shareholder value in the healthcare industry.

Key Highlights

  • 1HCA adopted the 2016 Senior Officer Performance Excellence Program (Senior Officer PEP) for its executive officers.
  • 2Executive incentive awards are primarily tied to achieving specific EBITDA targets (80-90% weighting).
  • 3A portion of the incentive awards (10-20% weighting) is linked to the achievement of quality of care metrics.
  • 4Named executive officers have defined target award opportunities based on a percentage of their base salary.
  • 5The program specifies payout structures for EBITDA performance, ranging from threshold to maximum levels.
  • 6Quality of care metric payouts can be enhanced if EBITDA targets are exceeded and are eliminated if EBITDA falls below 90% of target.
  • 7Awards are paid in cash and are subject to clawback or adjustment under certain conditions, including restatements of financial results or misconduct.

Frequently Asked Questions